Share Price and Basic Stock Data
Last Updated: February 7, 2026, 7:08 pm
| PEG Ratio | -0.81 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DE Nora India Ltd operates in the graphite electrodes industry, a critical sector for steel manufacturing and various industrial applications. As of October 2023, the company’s stock price stood at ₹585, with a market capitalization of ₹312 Cr. Revenue trends show a fluctuating performance over recent quarters. Sales recorded in September 2022 were ₹14.37 Cr, and rose to ₹27.63 Cr by March 2023. However, a decline to ₹9.14 Cr was noted in June 2023, followed by a recovery to ₹19.08 Cr in September 2023. The trailing twelve months (TTM) sales reached ₹102 Cr, indicating a potential solid revenue base. Nevertheless, the company’s revenue for FY 2025 is expected to be ₹69 Cr, a decline from the previous year’s ₹74 Cr. This stark variation in quarterly performance highlights the need for stability in operations and market positioning, particularly in a sector that often experiences cyclical demand.
Profitability and Efficiency Metrics
Profitability metrics reveal a mixed performance for DE Nora India Ltd. The operating profit margin (OPM) reported at 18.41% reflects a strong operational efficiency, particularly when compared to industry norms, which typically range lower. However, the company’s return on equity (ROE) stood at a mere 1.84%, significantly below the sector average, indicating inefficiencies in generating returns for shareholders. The net profit for the quarter ending September 2023 was ₹6.35 Cr, translating to an earnings per share (EPS) of ₹11.96. This figure marked a recovery from the preceding quarter’s EPS of ₹0.98 in June 2023. Despite these improvements, the interest coverage ratio (ICR) remained at 0.00x, suggesting a lack of debt servicing capacity, which is a concern given the company’s operational reliance without any borrowings, potentially limiting growth opportunities.
Balance Sheet Strength and Financial Ratios
DE Nora India Ltd’s balance sheet reflects a strong financial position with no reported borrowings, which enhances its financial stability. As of March 2025, the company’s reserves were recorded at ₹115 Cr, increasing from ₹96 Cr in March 2023. The current ratio stood at 4.97, indicating a robust liquidity position, well above the typical threshold of 1.5, suggesting that the company can comfortably meet its short-term liabilities. However, the price-to-book value ratio (P/BV) of 3.01x indicates a premium valuation compared to the book value of ₹226.33 per share. This may raise concerns among investors regarding overvaluation. Additionally, the cash conversion cycle (CCC) of 402.82 days signals inefficiencies in working capital management, particularly in inventory turnover, which could impact operational cash flow and overall efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of DE Nora India Ltd reveals significant promoter control, with promoters holding 53.68% of the equity. This concentrated ownership might indicate stability in management decisions but could also raise concerns about governance and minority shareholder interests. Foreign institutional investors (FIIs) have a minimal presence at 0.01%, while domestic institutional investors (DIIs) hold a slightly higher stake at 0.22%. The public shareholding stands at 46.10%, reflecting moderate retail interest. The total number of shareholders has decreased to 15,024 from a peak of 16,033 in December 2024, highlighting a potential decline in investor confidence. The lack of dividends since March 2025, where the payout ratio was 0%, may further deter investors seeking income, emphasizing the need for the company to enhance shareholder returns to boost confidence.
Outlook, Risks, and Final Insight
Looking ahead, DE Nora India Ltd faces both opportunities and challenges. The potential for revenue growth exists, particularly if the company can stabilize its quarterly sales and improve operational efficiencies. However, risks persist, particularly concerning its low ROE and high CCC, which may hinder performance. Additionally, the absence of debt could limit its capacity for strategic investments or expansions. Market dynamics, including fluctuations in demand for graphite electrodes and competition from other manufacturers, pose further risks. The company must address these operational inefficiencies and enhance shareholder returns to improve investor confidence. Should DE Nora India successfully implement strategies to stabilize revenue and optimize its operational structure, it could position itself favorably within the graphite electrodes market and attract greater institutional investment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HEG Ltd | 10,309 Cr. | 534 | 672/331 | 40.0 | 242 | 0.34 % | 3.96 % | 2.59 % | 2.00 |
| Graphite India Ltd | 12,088 Cr. | 619 | 685/366 | 50.2 | 301 | 1.78 % | 10.1 % | 8.00 % | 2.00 |
| DE Nora India Ltd | 312 Cr. | 588 | 995/559 | 24.0 | 240 | 0.00 % | 0.88 % | 1.84 % | 10.0 |
| Industry Average | 7,569.67 Cr | 580.33 | 38.07 | 261.00 | 0.71% | 4.98% | 4.14% | 4.67 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.19 | 27.63 | 9.14 | 19.08 | 29.40 | 16.18 | 12.76 | 18.13 | 17.56 | 20.13 | 41.97 | 21.84 | 35.84 |
| Expenses | 13.99 | 12.21 | 9.35 | 11.44 | 21.91 | 9.93 | 9.82 | 14.92 | 28.95 | 16.30 | 39.53 | 17.82 | 33.36 |
| Operating Profit | 5.20 | 15.42 | -0.21 | 7.64 | 7.49 | 6.25 | 2.94 | 3.21 | -11.39 | 3.83 | 2.44 | 4.02 | 2.48 |
| OPM % | 27.10% | 55.81% | -2.30% | 40.04% | 25.48% | 38.63% | 23.04% | 17.71% | -64.86% | 19.03% | 5.81% | 18.41% | 6.92% |
| Other Income | 1.49 | 1.29 | 1.16 | 1.14 | 1.19 | 1.71 | 1.34 | 1.65 | 1.50 | 1.37 | 2.36 | 1.70 | 1.43 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.25 | 0.24 | 0.25 | 0.25 | 0.29 | 0.35 | 0.40 | 0.42 | 0.44 | 0.45 | 0.46 | 0.52 | 0.52 |
| Profit before tax | 6.44 | 16.47 | 0.70 | 8.53 | 8.39 | 7.61 | 3.88 | 4.44 | -10.33 | 4.75 | 4.34 | 5.20 | 3.39 |
| Tax % | 25.31% | 25.14% | 25.71% | 25.56% | 22.77% | 25.76% | 25.77% | 26.35% | -24.30% | 29.68% | 25.12% | 25.58% | 23.89% |
| Net Profit | 4.81 | 12.32 | 0.52 | 6.35 | 6.48 | 5.66 | 2.88 | 3.28 | -7.81 | 3.34 | 3.25 | 3.87 | 2.57 |
| EPS in Rs | 9.06 | 23.21 | 0.98 | 11.96 | 12.21 | 10.66 | 5.43 | 6.18 | -14.71 | 6.29 | 6.12 | 7.29 | 4.84 |
Last Updated: February 6, 2026, 5:16 am
Below is a detailed analysis of the quarterly data for DE Nora India Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 35.84 Cr.. The value appears strong and on an upward trend. It has increased from 21.84 Cr. (Sep 2025) to 35.84 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Dec 2025, the value is 33.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.82 Cr. (Sep 2025) to 33.36 Cr., marking an increase of 15.54 Cr..
- For Operating Profit, as of Dec 2025, the value is 2.48 Cr.. The value appears to be declining and may need further review. It has decreased from 4.02 Cr. (Sep 2025) to 2.48 Cr., marking a decrease of 1.54 Cr..
- For OPM %, as of Dec 2025, the value is 6.92%. The value appears to be declining and may need further review. It has decreased from 18.41% (Sep 2025) to 6.92%, marking a decrease of 11.49%.
- For Other Income, as of Dec 2025, the value is 1.43 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Sep 2025) to 1.43 Cr., marking a decrease of 0.27 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2025, the value is 0.52 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.52 Cr..
- For Profit before tax, as of Dec 2025, the value is 3.39 Cr.. The value appears to be declining and may need further review. It has decreased from 5.20 Cr. (Sep 2025) to 3.39 Cr., marking a decrease of 1.81 Cr..
- For Tax %, as of Dec 2025, the value is 23.89%. The value appears to be improving (decreasing) as expected. It has decreased from 25.58% (Sep 2025) to 23.89%, marking a decrease of 1.69%.
- For Net Profit, as of Dec 2025, the value is 2.57 Cr.. The value appears to be declining and may need further review. It has decreased from 3.87 Cr. (Sep 2025) to 2.57 Cr., marking a decrease of 1.30 Cr..
- For EPS in Rs, as of Dec 2025, the value is 4.84. The value appears to be declining and may need further review. It has decreased from 7.29 (Sep 2025) to 4.84, marking a decrease of 2.45.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36 | 31 | 51 | 27 | 27 | 33 | 48 | 51 | 74 | 74 | 74 | 69 | 102 |
| Expenses | 29 | 25 | 35 | 25 | 25 | 32 | 38 | 42 | 51 | 49 | 52 | 70 | 103 |
| Operating Profit | 7 | 5 | 16 | 2 | 2 | 0 | 11 | 8 | 23 | 25 | 21 | -1 | -1 |
| OPM % | 19% | 17% | 30% | 8% | 8% | 1% | 22% | 17% | 31% | 34% | 29% | -2% | -1% |
| Other Income | 1 | 2 | 4 | 3 | 3 | 4 | 2 | 2 | 1 | 4 | 5 | 6 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 1 | 1 | 2 | 2 |
| Profit before tax | 7 | 6 | 18 | 4 | 3 | 2 | 10 | 8 | 21 | 27 | 25 | 3 | 4 |
| Tax % | 31% | 29% | 33% | 33% | 45% | 13% | 22% | 25% | 26% | 25% | 25% | 38% | |
| Net Profit | 5 | 4 | 12 | 3 | 2 | 2 | 8 | 6 | 15 | 20 | 19 | 2 | 3 |
| EPS in Rs | 9.00 | 8.01 | 22.57 | 5.61 | 3.18 | 3.00 | 15.31 | 10.64 | 29.10 | 38.20 | 35.81 | 3.18 | 4.99 |
| Dividend Payout % | 44% | 19% | 18% | 36% | 31% | 0% | 0% | 9% | 3% | 5% | 6% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -33.33% | 0.00% | 300.00% | -25.00% | 150.00% | 33.33% | -5.00% | -89.47% |
| Change in YoY Net Profit Growth (%) | 0.00% | 33.33% | 300.00% | -325.00% | 175.00% | -116.67% | -38.33% | -84.47% |
DE Nora India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | -3% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -23% |
| 3 Years: | -48% |
| TTM: | -90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 31% |
| 3 Years: | 5% |
| 1 Year: | -48% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 13% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 31 | 34 | 43 | 47 | 47 | 48 | 56 | 62 | 77 | 96 | 114 | 115 | 122 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 12 | 9 | 12 | 12 | 11 | 12 | 13 | 13 | 12 | 14 | 7 | 22 | 48 |
| Total Liabilities | 48 | 49 | 60 | 64 | 63 | 65 | 75 | 80 | 94 | 116 | 127 | 142 | 175 |
| Fixed Assets | 7 | 7 | 7 | 7 | 14 | 12 | 10 | 10 | 7 | 8 | 13 | 15 | 17 |
| CWIP | 1 | 1 | 2 | 7 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 1 |
| Investments | 8 | 14 | 19 | 20 | 20 | 14 | 5 | 4 | 23 | 42 | 54 | 52 | 74 |
| Other Assets | 33 | 26 | 32 | 29 | 29 | 40 | 60 | 66 | 62 | 64 | 57 | 73 | 84 |
| Total Assets | 48 | 49 | 60 | 64 | 63 | 65 | 75 | 80 | 94 | 116 | 127 | 142 | 175 |
Below is a detailed analysis of the balance sheet data for DE Nora India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2025) to 122.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Mar 2025) to 48.00 Cr., marking an increase of 26.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 175.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 142.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 33.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 74.00 Cr., marking an increase of 22.00 Cr..
- For Other Assets, as of Sep 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 11.00 Cr..
- For Total Assets, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 33.00 Cr..
Notably, the Reserves (122.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 7.00 | 5.00 | 16.00 | 2.00 | 2.00 | 0.00 | 10.00 | 8.00 | 23.00 | 25.00 | 21.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 131.38 | 139.09 | 74.97 | 81.84 | 64.14 | 61.24 | 97.25 | 78.79 | 57.97 | 84.48 | 50.55 | 71.42 |
| Inventory Days | 298.87 | 229.19 | 130.01 | 197.82 | 398.23 | 516.42 | 471.41 | 272.94 | 288.42 | 397.03 | 401.25 | 412.83 |
| Days Payable | 69.54 | 66.71 | 79.72 | 113.65 | 263.55 | 181.89 | 82.99 | 46.94 | 36.90 | 90.83 | 51.25 | 81.43 |
| Cash Conversion Cycle | 360.72 | 301.58 | 125.26 | 166.01 | 198.83 | 395.77 | 485.67 | 304.79 | 309.49 | 390.68 | 400.55 | 402.82 |
| Working Capital Days | 140.56 | 144.35 | 45.02 | 13.96 | 48.34 | 135.73 | 218.41 | 155.56 | 131.98 | 163.85 | 157.28 | 127.79 |
| ROCE % | 20.94% | 16.46% | 41.15% | 8.95% | 6.10% | 3.67% | 17.97% | 11.92% | 28.43% | 29.67% | 21.96% | 0.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.64 |
| Diluted EPS (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.64 |
| Cash EPS (Rs.) | 6.39 | 37.96 | 40.77 | 34.13 | 15.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 226.33 | 225.46 | 191.53 | 154.24 | 126.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 226.33 | 225.46 | 191.53 | 154.24 | 126.16 |
| Dividend / Share (Rs.) | 0.00 | 2.00 | 2.00 | 1.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 129.19 | 139.01 | 138.60 | 139.71 | 95.20 |
| PBDIT / Share (Rs.) | 8.39 | 49.67 | 53.75 | 44.79 | 19.17 |
| PBIT / Share (Rs.) | 5.19 | 47.52 | 51.17 | 39.76 | 14.27 |
| PBT / Share (Rs.) | 5.19 | 47.52 | 51.15 | 39.48 | 14.27 |
| Net Profit / Share (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.63 |
| PBDIT Margin (%) | 6.49 | 35.73 | 38.78 | 32.05 | 20.13 |
| PBIT Margin (%) | 4.01 | 34.18 | 36.92 | 28.45 | 14.98 |
| PBT Margin (%) | 4.01 | 34.18 | 36.90 | 28.25 | 14.98 |
| Net Profit Margin (%) | 2.46 | 25.75 | 27.55 | 20.83 | 11.17 |
| Return on Networth / Equity (%) | 1.40 | 15.88 | 19.94 | 18.86 | 8.42 |
| Return on Capital Employeed (%) | 2.28 | 21.07 | 26.61 | 25.77 | 11.30 |
| Return On Assets (%) | 1.18 | 15.00 | 17.53 | 16.49 | 7.09 |
| Asset Turnover Ratio (%) | 0.50 | 0.60 | 0.70 | 0.85 | 0.65 |
| Current Ratio (X) | 4.97 | 14.48 | 7.61 | 7.06 | 5.38 |
| Quick Ratio (X) | 3.54 | 10.52 | 5.50 | 5.03 | 3.84 |
| Inventory Turnover Ratio (X) | 2.33 | 0.72 | 1.02 | 1.27 | 1.15 |
| Dividend Payout Ratio (NP) (%) | 62.71 | 5.58 | 2.61 | 3.43 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.28 | 5.26 | 2.45 | 2.92 | 0.00 |
| Earning Retention Ratio (%) | 37.29 | 94.42 | 97.39 | 96.57 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.72 | 94.74 | 97.55 | 97.08 | 0.00 |
| Interest Coverage Ratio (X) | 0.00 | 0.00 | 2194.98 | 159.15 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 0.00 | 1560.69 | 104.42 | 0.00 |
| Enterprise Value (Cr.) | 350.13 | 858.53 | 434.79 | 190.91 | 103.33 |
| EV / Net Operating Revenue (X) | 5.11 | 11.63 | 5.91 | 2.57 | 2.04 |
| EV / EBITDA (X) | 78.56 | 32.56 | 15.24 | 8.03 | 10.15 |
| MarketCap / Net Operating Revenue (X) | 5.27 | 11.74 | 6.12 | 2.86 | 2.64 |
| Retention Ratios (%) | 37.28 | 94.41 | 97.38 | 96.56 | 0.00 |
| Price / BV (X) | 3.01 | 7.24 | 4.43 | 2.59 | 1.99 |
| Price / Net Operating Revenue (X) | 5.27 | 11.74 | 6.12 | 2.86 | 2.64 |
| EarningsYield | 0.00 | 0.02 | 0.04 | 0.07 | 0.04 |
After reviewing the key financial ratios for DE Nora India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.39. This value is within the healthy range. It has decreased from 37.96 (Mar 24) to 6.39, marking a decrease of 31.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 226.33. It has increased from 225.46 (Mar 24) to 226.33, marking an increase of 0.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 226.33. It has increased from 225.46 (Mar 24) to 226.33, marking an increase of 0.87.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 2.00 (Mar 24) to 0.00, marking a decrease of 2.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 129.19. It has decreased from 139.01 (Mar 24) to 129.19, marking a decrease of 9.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 49.67 (Mar 24) to 8.39, marking a decrease of 41.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.19. This value is within the healthy range. It has decreased from 47.52 (Mar 24) to 5.19, marking a decrease of 42.33.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.19. This value is within the healthy range. It has decreased from 47.52 (Mar 24) to 5.19, marking a decrease of 42.33.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.19. This value is within the healthy range. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For PBDIT Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 10. It has decreased from 35.73 (Mar 24) to 6.49, marking a decrease of 29.24.
- For PBIT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has decreased from 34.18 (Mar 24) to 4.01, marking a decrease of 30.17.
- For PBT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has decreased from 34.18 (Mar 24) to 4.01, marking a decrease of 30.17.
- For Net Profit Margin (%), as of Mar 25, the value is 2.46. This value is below the healthy minimum of 5. It has decreased from 25.75 (Mar 24) to 2.46, marking a decrease of 23.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 1.40, marking a decrease of 14.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 10. It has decreased from 21.07 (Mar 24) to 2.28, marking a decrease of 18.79.
- For Return On Assets (%), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 5. It has decreased from 15.00 (Mar 24) to 1.18, marking a decrease of 13.82.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 0.60 (Mar 24) to 0.50, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 4.97. This value exceeds the healthy maximum of 3. It has decreased from 14.48 (Mar 24) to 4.97, marking a decrease of 9.51.
- For Quick Ratio (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 2. It has decreased from 10.52 (Mar 24) to 3.54, marking a decrease of 6.98.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.33. This value is below the healthy minimum of 4. It has increased from 0.72 (Mar 24) to 2.33, marking an increase of 1.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 62.71. This value exceeds the healthy maximum of 50. It has increased from 5.58 (Mar 24) to 62.71, marking an increase of 57.13.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.28. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 31.28, marking an increase of 26.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 37.29. This value is below the healthy minimum of 40. It has decreased from 94.42 (Mar 24) to 37.29, marking a decrease of 57.13.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.72. This value is within the healthy range. It has decreased from 94.74 (Mar 24) to 68.72, marking a decrease of 26.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Enterprise Value (Cr.), as of Mar 25, the value is 350.13. It has decreased from 858.53 (Mar 24) to 350.13, marking a decrease of 508.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.11. This value exceeds the healthy maximum of 3. It has decreased from 11.63 (Mar 24) to 5.11, marking a decrease of 6.52.
- For EV / EBITDA (X), as of Mar 25, the value is 78.56. This value exceeds the healthy maximum of 15. It has increased from 32.56 (Mar 24) to 78.56, marking an increase of 46.00.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.27. This value exceeds the healthy maximum of 3. It has decreased from 11.74 (Mar 24) to 5.27, marking a decrease of 6.47.
- For Retention Ratios (%), as of Mar 25, the value is 37.28. This value is within the healthy range. It has decreased from 94.41 (Mar 24) to 37.28, marking a decrease of 57.13.
- For Price / BV (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has decreased from 7.24 (Mar 24) to 3.01, marking a decrease of 4.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.27. This value exceeds the healthy maximum of 3. It has decreased from 11.74 (Mar 24) to 5.27, marking a decrease of 6.47.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DE Nora India Ltd:
- Net Profit Margin: 2.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.28% (Industry Average ROCE: 4.98%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.4% (Industry Average ROE: 4.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.54
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24 (Industry average Stock P/E: 38.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electrodes - Graphite | Plot Nos 184,185 & 189, Kundaim Goa 403115 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Supriya Banerji | Chairperson & Independent Director |
| Mr. Vinay Chopra | Managing Director |
| Mr. Francesco L�Abbate | Non Executive Director |
| Mr. Robert Scannell | Non Executive Director |
| Mr. Purushottam Mantri | Independent Director |
| Ms. Lalita Correia Afonso | Independent Director |
FAQ
What is the intrinsic value of DE Nora India Ltd?
DE Nora India Ltd's intrinsic value (as of 09 February 2026) is ₹60.78 which is 89.66% lower the current market price of ₹588.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹312 Cr. market cap, FY2025-2026 high/low of ₹995/559, reserves of ₹122 Cr, and liabilities of ₹175 Cr.
What is the Market Cap of DE Nora India Ltd?
The Market Cap of DE Nora India Ltd is 312 Cr..
What is the current Stock Price of DE Nora India Ltd as on 09 February 2026?
The current stock price of DE Nora India Ltd as on 09 February 2026 is ₹588.
What is the High / Low of DE Nora India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DE Nora India Ltd stocks is ₹995/559.
What is the Stock P/E of DE Nora India Ltd?
The Stock P/E of DE Nora India Ltd is 24.0.
What is the Book Value of DE Nora India Ltd?
The Book Value of DE Nora India Ltd is 240.
What is the Dividend Yield of DE Nora India Ltd?
The Dividend Yield of DE Nora India Ltd is 0.00 %.
What is the ROCE of DE Nora India Ltd?
The ROCE of DE Nora India Ltd is 0.88 %.
What is the ROE of DE Nora India Ltd?
The ROE of DE Nora India Ltd is 1.84 %.
What is the Face Value of DE Nora India Ltd?
The Face Value of DE Nora India Ltd is 10.0.